218 results
Page 5 of 11
8-K
EX-99.1
s5nap ngy3
6 May 20
Cassava Sciences Reports First Quarter 2020 Financial Results and Provides Business Update
8:16am
424B2
ih33bt6w6wr
5 May 20
Prospectus for primary offering
4:38pm
8-K
EX-99.1
3skq3qxr 7h
26 Mar 20
Cassava Sciences Announces Full-year 2019 Financial Results and Anticipated Key Milestones for 2020
8:17am
8-K
EX-99.1
fp5sgjseq w9o
6 Dec 19
Regulation FD Disclosure
4:40pm
8-K
EX-99.2
lq99dr
6 Dec 19
Regulation FD Disclosure
4:40pm
8-K
EX-99.1
isei 1abyftuaiy16l4
29 Oct 19
Cassava Sciences Announces Recent Clinical Highlights and Third Quarter 2019 Financial Results
8:29am
8-K
EX-99.1
nhw8fvsn0aw7aubqx5
9 Sep 19
Cassava Sciences Reports Positive Phase 2a Clinical Results in Alzheimer’s Patients
7:45am
8-K
EX-99.1
vny2sev4 juk
12 Aug 19
Cassava Sciences Announces Second Quarter 2019 Financial Results
3:05pm
8-K
EX-99.1
rit8 drkqcl25r28
29 Apr 19
Cassava Sciences Reports First Quarter 2019 Financial Results
8:45am
8-K
EX-99.1
5zy o4kkq2rxesfr
27 Mar 19
Pain Therapeutics Announces Name Change to
3:02pm